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Background
Oral food challenges are the gold standard for clinical
tolerance. Predictors of failing a challenge are needed
for clinicians.
Methods
A retrospective chart review of 2010 food challenges was
performed. Descriptive analysis follows.
Results
We assessed 113 challenges (35 peanut, 28 egg, 12 tree nut,
11 milk, 27 other). There were 29 failures (22 objective,
7 subjective). Among objective challenge failures, 4/7
cashew (57%), 10/35 (29%) peanut, and 6/28 egg (21%)
failed. There were no failed milk challenges. Most (79%)
failed peanut/cashew challenges occurred at doses ≤1.0g
while 50% of failed egg challenges were final dose (10g).
Three children required epinephrine (all cashew), none of
whom had a prior known exposure (skin tested 2° peanut/
almond). For peanut failures, 40% were history negative.
The remainder of the challenge failure reactions were simi-
lar to the presenting reaction. Factors for failed challenges
compared with successful challenges included atopic der-
matitis (100% v 75%), asthma (93% v 63%), and other food
allergy (64% v 48%).
Conclusions
The majority of challenge failures were to peanut while the
most severe reactions were to cashew, and occurred in
patients without prior known exposure. Failures to peanut
and cashew occurred at low doses while most egg reac-
tions occurred at high doses. Those who failed a challenge
had more atopic disease than those who passed.
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